BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Murata S, Mine T, Sugihara F, Yasui D, Yamaguchi H, Ueda T, Onozawa S, Kumita SI. Interventional treatment for unresectable hepatocellular carcinoma. World J Gastroenterol 2014; 20(37): 13453-13465 [PMID: 25309076 DOI: 10.3748/wjg.v20.i37.13453]
URL: https://www.wjgnet.com/1948-5182/full/v20/i37/13453.htm
Number Citing Articles
1
Yaoping Shi, Bo Zhai. A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular CarcinomaGastrointestinal Tumors 2016; 3(2): 90 doi: 10.1159/000445888
2
Houqiao Bai, Peng Gao, Hao Gao, Guangxi Sun, Chonghai Dong, Jian Han, Guosheng Jiang. Improvement of Survival Rate for Patients with Hepatocellular Carcinoma Using Transarterial Chemoembolization in Combination with Three-Dimensional Conformal Radiation Therapy: A Meta-AnalysisMedical Science Monitor 2016; 22: 1773 doi: 10.12659/MSM.895548
3
B. T. Welch, J. J. Schmitz, T. D. Atwell, A. M. McGauvran, A. N. Kurup, M. R. Callstrom, G. D. Schmit. Evaluation of infectious complications following percutaneous liver ablation in patients with bilioenteric anastomosesAbdominal Radiology 2017; 42(5): 1579 doi: 10.1007/s00261-017-1051-5
4
Sirish A. Kishore, Raazi Bajwa, David C. Madoff. Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 UpdateCancers 2020; 12(4): 791 doi: 10.3390/cancers12040791
5
Chang-Hsien Liu, Cheng-Ming Peng, Jen-I. Hwang, Po-Chin Liang, Pei-Jer Chen, Nadine Abi-Jaoudeh, Lung-Hui Giiang, Yu-Shen Tyan. Phase I Dose-Escalation Study of Tirapazamine Chemoembolization for Unresectable Early- and Intermediate-Stage Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology 2022; 33(8): 926 doi: 10.1016/j.jvir.2022.04.031
6
Roberto Iezzi, Maurizio Pompili, Emanuele Rinninella, Eleonora Annicchiarico, Matteo Garcovich, Lucia Cerrito, Francesca Ponziani, AnnaMaria De Gaetano, Massimo Siciliano, Michele Basso, Maria Assunta Zocco, GianLodovico Rapaccini, Alessandro Posa, Francesca Carchesio, Marco Biolato, Felice Giuliante, Antonio Gasbarrini, Riccardo Manfredi. TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenibEuropean Radiology 2019; 29(3): 1285 doi: 10.1007/s00330-018-5692-8
7
Dong Lv, Yuan Wang, Ying Zhang, Peilin Cui, Youqing Xu. Downregulated long non-coding RNA DREH promotes cell proliferation in hepatitis B virus-associated hepatocellular carcinomaOncology Letters 2017; 14(2): 2025 doi: 10.3892/ol.2017.6436
8
Yuko Takami, Susumu Eguchi, Masaki Tateishi, Tomoki Ryu, Kazuhiro Mikagi, Yoshiyuki Wada, Hideki Saitsu. A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatmentHepatology International 2016; 10(5): 799 doi: 10.1007/s12072-016-9704-y
9
Yi-Lan Lin. Proton beam therapy in apneic oxygenation treatment of an unresectable hepatocellular carcinoma: A case report and review of literatureWorld Journal of Hepatology 2018; 10(10): 772-779 doi: 10.4254/wjh.v10.i10.772
10
Pietro Di Fazio, Petra Waldegger, Samir Jabari, Susanne Lingelbach, Roberta Montalbano, Matthias Ocker, Emily P. Slater, Detlef K. Bartsch, Romana Illig, Daniel Neureiter, Thaddeus T. Wissniowski. Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancerOncotarget 2016; 7(20): 28998 doi: 10.18632/oncotarget.8585
11
Daisuke Yasui, Satoru Murata, Tatsuo Ueda, Fumie Sugihara, Shiro Onozawa, Chiaki Kawamoto, Shinichiro Kumita. Novel treatment strategy for advanced hepatocellular carcinoma: combination of conventional transcatheter arterial chemoembolization and modified method with portal vein occlusion for cases with arterioportal shunt: a preliminary studyActa Radiologica 2018; 59(3): 266 doi: 10.1177/0284185117717762
12
Roberto Iezzi, Alessandro Posa, Marco Santoro, Alessandro Tanzilli, Lucia Cerrito, Francesca Romana Ponziani, Maurizio Pompili, Antonio Grieco, Gian Ludovico Rapaccini, Antonio Gasbarrini, Riccardo Manfredi. Balloon-Occluded Radiofrequency Ablation as Bridge to TACE in the Treatment of Advanced HCC with Arterioportal ShuntCurrent Radiopharmaceuticals 2022; 15(3): 194 doi: 10.2174/1874471015666220223102426
13
Jungang Hu, Majid Maybody, Guang Cao, Xiao Wang, Hui Chen, Xu Zhu, Renjie Yang, Xiaodong Wang. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with responseCancer Imaging 2016; 16(1) doi: 10.1186/s40644-016-0090-4
14
Asanda Koza, Ricky H. Bhogal, Nicos Fotiadis, Vasileios K. Mavroeidis. The Role of Ablative Techniques in the Management of Hepatocellular Carcinoma: Indications and OutcomesBiomedicines 2023; 11(4): 1062 doi: 10.3390/biomedicines11041062
15
Ali Habib, Kush Desai, Ryan Hickey, Bartley Thornburg, Robert Lewandowski, Riad Salem. Locoregional Therapy of Hepatocellular CarcinomaClinics in Liver Disease 2015; 19(2): 401 doi: 10.1016/j.cld.2015.01.008
16
Jingxin Yan, Manjun Deng, Ting Li, Changhao Dong, Minglan Wang, Shunyu Kong, Yingxing Guo, Haining Fan. Efficacy and complications of transarterial chemoembolization alone or in combination with different protocols for hepatocellular carcinoma: A Bayesian network meta-analysis of randomized controlled trialsiLIVER 2023; 2(2): 130 doi: 10.1016/j.iliver.2023.03.002
17
Xiu-Li Gao, Hua Lin, Wei Zhao, Ya-Qin Hou, Yong-Li Bao, Zhen-Bo Song, Lu-Guo Sun, Shang-Yi Tian, Biao Liu, Yu-Xin Li. JA, a new type of polyunsaturated fatty acid isolated from Juglans mandshurica Maxim, limits the survival and induces apoptosis of heptocarcinoma cellsApoptosis 2016; 21(3): 340 doi: 10.1007/s10495-015-1202-5
18
Brian T. Welch, J. J. Schmitz, A. N. Kurup, T. D. Atwell, M. R. Callstrom, G. Frey, R. Paz-Fumagalli, A. Allen, K. Watt, J. Heimbach, G. D. Schmit. Feasibility and outcomes of percutaneous thermal ablation of hepatocellular carcinoma in a transplanted allograftAbdominal Radiology 2018; 43(6): 1478 doi: 10.1007/s00261-017-1323-0
19
Kung-Hao Liang, Chih-Lang Lin, Sung-Fang Chen, Chih-Wei Chiu, Pei-Ching Yang, Ming-Ling Chang, Chen-Chun Lin, Kai-Feng Sung, Cassandra Yeh, Chien-Fu Hung, Rong-Nan Chien, Chau-Ting Yeh. GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolizationPharmacogenomics 2016; 17(4): 353 doi: 10.2217/pgs.15.179
20
Gabor Varbiro. Enhancement of the Cytotoxic Effect of Anticancer Agent by Cytochrome c Functionalised Hybrid Nanoparticles in Hepatocellular Cancer CellsJournal of Nanomedicine Research 2014; 1(2) doi: 10.15406/jnmr.2014.01.00010
21
Ni Zeng, Ye Wang, Yuan Wan, Hongyu Wang, Nan Li. The Antitumor Impact of Combining Hepatic Artery Ligation With Copper Chelators for Liver CancerClinical Medicine Insights: Oncology 2023; 17 doi: 10.1177/11795549231204612
22
Fumie Sugihara, Satoru Murata, Tatsuo Ueda, Daisuke Yasui, Hidenori Yamaguchi, Izumi Miki, Chiaki Kawamoto, Eiji Uchida, Shin-ichiro Kumita. Haemodynamic changes in hepatocellular carcinoma and liver parenchyma under balloon occlusion of the hepatic arteryEuropean Radiology 2017; 27(6): 2474 doi: 10.1007/s00330-016-4573-2
23
Dongyan Wu, Huaisong Wang, Xiaoshuang Hou, Huan Chen, Yu Ma, Yanglong Hou, Jin Hong, Ya Ding. Effects of gold core size on regulating the performance of doxorubicin-conjugated gold nanoparticlesNano Research 2018; 11(6): 3396 doi: 10.1007/s12274-017-1963-y
24
Liming Lu, Jingchun Zeng, Zehuai Wen, Chunzhi Tang, Nenggui Xu. Transcatheter arterial chemoembolisation followed by three-dimensional conformal radiotherapy versus transcatheter arterial chemoembolisation alone for primary hepatocellular carcinoma in adultsCochrane Database of Systematic Reviews 2019; 2019(2) doi: 10.1002/14651858.CD012244.pub2
25
Hanyao Sun, Wei Yang, Weizhong Zhou, Chungao Zhou, Sheng Liu, Haibin Shi, Wei Tian. Prognostic value of des‑γ‑carboxyprothrombin in patients with AFP‑negative HCC treated with TACEOncology Letters 2022; 25(2) doi: 10.3892/ol.2022.13655
26
Liming Lu, Jingchun Zeng, Zehuai Wen. Combination of three-dimensional conformal radiotherapy and transcatheter arterial chemoembolisation versus transcatheter arterial chemoembolisation for primary hepatocellular carcinomaCochrane Database of Systematic Reviews 2016;  doi: 10.1002/14651858.CD012244
27
Long Gao, Jian Zhang, Tengchuang Ma, Nan Yao, Meng Gao, Xin Shan, Yicheng Ni, Haibo Shao, Ke Xu. Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapyOncotarget 2016; 7(32): 51450 doi: 10.18632/oncotarget.9848
28
Abdalla Aly, Melissa Lingohr-Smith, Jay Lin, Brian Seal. Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USAHepatic Oncology 2021; 8(3) doi: 10.2217/hep-2021-0001
29
Jingxin Yan, Manjun Deng, Ting Li, Yaxuan Wang, Jiaxin Wu, LuShun Zhang, Haining Fan. Transarterial chemoembolisation plus I125 seeds implantation for people with unresectable hepatocellular carcinomaCochrane Database of Systematic Reviews 2022; 2022(12) doi: 10.1002/14651858.CD015389
30
Zhaoyuan Liu, Qing Peng, Yang Li, Yi Gao. Resveratrol enhances cisplatin-induced apoptosis in human hepatoma cells via glutamine metabolism inhibitionBMB Reports 2018; 51(9): 474 doi: 10.5483/BMBRep.2018.51.9.114
31
Chang Jin Yoon, Jin Wook Chung. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set2017; : 1398 doi: 10.1016/B978-0-323-34062-5.00096-0
32
Jianghai Zhao, Hui Zhang, Lunshou Wei, Shuping Xie, Zhimin Suo. Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparisonOncotarget 2017; 8(9): 15101 doi: 10.18632/oncotarget.13145
33
Feng Xia, Qiao Zhang, Xiaoping Chen, Bixiang Zhang, Elijah Ndhlovu, Mingyu Zhang, Peng Zhu. Comparison of the prognosis of BCLC stage A ruptured hepatocellular carcinoma patients after undergoing transarterial chemoembolization (TACE) or hepatectomy: a propensity score-matched landmark analysisSurgical Endoscopy 2022; 36(12): 8992 doi: 10.1007/s00464-022-09351-2